Work

Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity

Year: 2001

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2001.19.8.2153

Authors: John C. Byrd, Timothy Murphy, Robin S. Howard, Margaret S. Lucas, Amy Goodrich, Kathy Park, Michael Pearson, Jamie K. Waselenko, Geoffrey Ling, Michael R. Grever, Antonio J. Grillo-Lopez, Jay Rosenberg, Lori Kunkel, Ian W. Flinn

Institutions: Johns Hopkins University, Uniformed Services University of the Health Sciences, Genentech, Johns Hopkins Medicine, Walter Reed National Military Medical Center, The Ohio State University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2116262245

FWCI: 22.17

Cites: 31

Cited by: 508

Related to: 10